Suppr超能文献

基于邻苯二甲酸醋酸纤维素的 pH 响应型环孢素 A 载药接触镜治疗干眼症。

Cellulose Acetate Phthalate-Based pH-Responsive Cyclosporine A-Loaded Contact Lens for the Treatment of Dry Eye.

机构信息

Department of Ophthalmology, Chonnam National University Medical School and Hospital, Gwangju 61469, Republic of Korea.

College of Pharmacy, Chosun University, Gwangju 61452, Republic of Korea.

出版信息

Int J Mol Sci. 2023 Jan 25;24(3):2361. doi: 10.3390/ijms24032361.

Abstract

Cyclosporine A (CsA) as an eye drop is an effective treatment for dry eye. However, it has potential side effects and a short ocular residence time. To overcome these obstacles, we developed a cellulose acetate phthalate-based pH-responsive contact lens (CL) loaded with CsA (CsA-CL). The CsA was continuously released from the CsA-CL at physiological conditions (37 °C, pH 7.4) without an initial burst. CsA was well-contained in the selected storage condition (4 °C, pH 5.4) for as long as 90 days. In safety assays, cytotoxicity, ocular irritation, visible light transmittance, and oxygen permeability were in a normal range. CsA concentrations in the conjunctiva, cornea, and lens increased over time until 12 h. When comparing the therapeutic efficacy between the normal control, experimental dry eye (EDE), and treatment groups (CsA eye drop, naïve CL, and CsA-CL groups), the tear volume, TBUT, corneal fluorescein staining at 7 and 14 days, conjunctival goblet cell density, and corneal apoptotic cell counts at 14 days improved in all treatment groups compared to EDE, with a significantly better result in the CsA-CL group compared with other groups (all < 0.05). The CsA-CL could be an effective, stable, and safe option for inflammatory dry eye.

摘要

环孢素 A(CsA)滴眼是治疗干眼症的有效方法。然而,它有潜在的副作用和短暂的眼部驻留时间。为了克服这些障碍,我们开发了一种基于醋酸纤维素邻苯二甲酸酯的 pH 响应接触镜(CL),负载 CsA(CsA-CL)。CsA 在生理条件(37°C,pH7.4)下从 CsA-CL 持续释放,没有初始突释。CsA 在选定的储存条件(4°C,pH5.4)下可保持 90 天以上。在安全性测定中,细胞毒性、眼刺激性、可见光透过率和氧气透过率均处于正常范围。CsA 在结膜、角膜和晶状体中的浓度随时间增加,直到 12 小时。在正常对照、实验性干眼(EDE)和治疗组(CsA 滴眼液、空白 CL 和 CsA-CL 组)之间的疗效比较中,与 EDE 相比,所有治疗组的泪液体积、泪膜破裂时间(TBUT)、第 7 天和第 14 天角膜荧光素染色、结膜杯状细胞密度和第 14 天角膜凋亡细胞计数均有所改善,CsA-CL 组的改善效果明显优于其他组(均<0.05)。CsA-CL 可能是一种有效、稳定和安全的治疗炎症性干眼的选择。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a98/9916649/301e09b90576/ijms-24-02361-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验